A31.8
Other mycobacterial infections
Clinical Classification Guidelines
Medical Intelligence & Overview
Other mycobacterial infections, classified under ICD-10 code A31.8, refer to a group of infections caused by various mycobacteria that do not fall under the more common categories such as tuberculosis or leprosy. These infections can affect different parts of the body and may present with a range of symptoms depending on the site of infection. They often develop in individuals with compromised immune systems, but can also impact otherwise healthy people. Recognizing these infections is important for appropriate diagnosis and management.
Causes & Symptoms
Clinical Causes: Exposure to environmental mycobacteria present in soil, water, or dust Contact with contaminated medical equipment or substances Inhalation of airborne mycobacteria in certain occupational settings Trauma or skin injuries that introduce bacteria into the skin or tissues Weakening of the immune system due to conditions like HIV/AIDS, chemotherapy, or immunosuppressive medications
Key Symptoms: Persistent skin nodules, ulcers, or abscesses Chronic cough or respiratory issues if the lungs are involved Fever and night sweats Weight loss and fatigue Swollen lymph nodes Localized pain or redness in affected areas Wounds that heal slowly or not at all
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation, laboratory testing, and imaging studies. Microbiological cultures from affected tissues or fluids are essential to identify specific mycobacteria. Additional tests such as acid-fast bacilli (AFB) staining, PCR, and histopathology may be used to confirm the presence of mycobacterial organisms. Imaging techniques like X-rays or MRI can help assess the extent of internal involvement.
Treatment Protocols: Treatment for other mycobacterial infections often requires prolonged courses of specific antibiotics tailored to the identified organism. These regimens may include drugs such as macrolides, aminoglycosides, or ethambutol. Management also involves addressing any underlying immune deficiencies and providing supportive care. Due to the potential for drug resistance and side effects, treatment plans are usually overseen by specialists in infectious diseases.
Clinical Advice & FAQs
Billing Guidance
Is A31.8 a billable ICD-10 code?
Yes, A31.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A31.8?
Clinical documentation must specify the nature of Other mycobacterial infections and any associated comorbidities for accurate reporting.
Cite this Clinical Reference